Abstract
N-Ureido-quinoxalinedione derivatives have been discovered as leads for a novel series of dipeptidyl peptidase-IV (DPP-IV) inhibitors through high-throughput screening of our chemical library. A brief structure-activity relationship of the compounds was investigated. Among them, entry 5 showed the most potent inhibitory activity. The nitro group in quinoxaline moiety and the aromatic sulfonyl substituted ureido functional group seem to be important to increase the potency dramatically.
| Original language | English |
|---|---|
| Pages (from-to) | 2661-2664 |
| Number of pages | 4 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 14 |
| Issue number | 10 |
| DOIs | |
| State | Published - 2004.05.17 |
Quacquarelli Symonds(QS) Subject Topics
- Medicine
- Engineering - Petroleum
- Pharmacy & Pharmacology
- Chemistry
- Biological Sciences
Fingerprint
Dive into the research topics of 'Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver